Ireland
--:--IST
Starting soon Observational

Investigation of the Relationship Between Shoulder Alpha Angle and Humeral Head Displacement Percentage Measured by Ultrasonography in Neonatal Brachial Plexus Palsy Infants With Clinical Parameters

NCT07768904 · tracked via the Priya Life Science Turkey tracker
Phase
Observational
Started
2026-08
Last updated
2026-08-17

Condition(s) studied

Glenohumeral SubluxationNeonatal Brachial Plexus PalsyBrachial Plexus Injuries

Investigational drug(s) / intervention(s)

Shoulder UltrasonographyStandardized Clinical Examination

Shoulder Ultrasonography: Ultrasonographic measurement of the shoulder alpha angle and percentage of humeral head displacement (PHHD), to be performed at each clinical visit.

Standardized Clinical Examination: Standardized physical examination including passive range of motion, Active Movement Scale, Toronto Test Score, and subluxation-specific clinical signs, to be performed at each visit.

Study summary

This study will examine infants with a birth-related nerve injury called neonatal brachial plexus palsy, which can affect movement in the arm and sometimes cause the shoulder joint to shift out of its normal position (subluxation). Researchers will use ultrasound imaging to measure the shoulder joint and will compare these measurements with findings from a physical examination, to determine which clinical signs can help predict whether a baby's shoulder will develop this problem. The goal is to help doctors detect shoulder problems earlier, so that treatment can start sooner.

Eligibility

Sex
ALL
Min age
3 Months
Max age
1 Year
Healthy volunteers
No
Inclusion Criteria: * Diagnosis of neonatal brachial plexus injury (NBPI) between 3 months and 1 year of age * Narakas classification Group I, II, or III * Absence of nerve root avulsion Exclusion Criteria: * Prior shoulder surgery for NBPI * Inability to tolerate ultrasonographic examination * Concomitant musculoskeletal (e.g., torticollis, humeral fracture) or neurological disease * Bilateral NBPI * Narakas classification Group IV * Botulinum toxin injection to the affected shoulder

Primary outcome measure(s)

  • Ultrasonographic Alpha Angle — Assessed at each clinical visit from 3 months to 1 year of age
    Alpha angle will be measured sonographically at each shoulder examination. Glenohumeral subluxation will be defined as an alpha angle greater than 30 degrees.
  • Percentage of Humeral Head Displacement (PHHD) — Assessed at each clinical visit from 3 months to 1 year of age
    PHHD will be measured sonographically at each shoulder examination. Glenohumeral dislocation will be defined as an alpha angle greater than 30 degrees combined with PHHD greater than 50%.

Trial sites (1)

FacilityCityRegionStatus
University of Health Sciences Turkey, Fatih Sultan Mehmet Training and Research Hospital Istanbul Turkey (Türkiye)

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07768904 on ClinicalTrials.gov ↗ ← All trials in Turkey